Results 1 to 10 of about 187,113 (345)
The association of vitamin D deficiency with non-alcoholic fatty liver disease [PDF]
Clinics, 2014 OBJECTIVE: Vitamin D deficiency has been related to diabetes, hypertension, hyperlipidemia and peripheral vascular disease. In this study, we aimed to investigate the role of vitamin D status in non-alcoholic fatty liver disease.
Metin Küçükazman +13 more
doaj +5 more sources
Statins and non-alcoholic fatty liver disease [PDF]
Liver International, 2019 Dear Editor, In April 9 issue, van den Berg et al1 report interesting results on the indication for lipid‐lowering treatment in a large cohort with suspected non‐alcoholic fatty liver disease (NAFLD) within the population‐based Lifelines Cohort Study.
Angelico, F +3 more
core +3 more sources
NON-ALCOHOLIC FATTY LIVER DISEASE [PDF]
, 2015 Paralelno s porastom prevalencije pretilosti i metaboličkog sindroma nealkoholna masna bolest jetre - NAFLD (engl. Non-Alcoholic Fatty Liver Disease) sve se više prepoznaje kao najčešća bolest jetre odraslih i djece.
ALEKSANDAR LJUBOTINA +4 more
core +6 more sources
Non-alcoholic fatty liver disease [PDF]
BMC Medicine, 2017 Non-alcoholic fatty liver disease has emerged a major challenge because of it prevalence, difficulties in diagnosis, complex pathogenesis, and lack of approved therapies. As the burden of hepatitis C abates over the next decade, non-alcoholic fatty liver disease will become the major form of chronic liver disease in adults and children and could become
Brent A. Neuschwander-Tetri
core +8 more sources
Non alcoholic fatty liver disease
Annals of Hepatology, 2009 A 45 year old man with known hypertension, type 2 diabetes mellitus, and central obesity presents with fatigue and mild discomfort in the abdominal right upper quadrant. Repeated blood tests show a persistent alanine aminotransferase concentration of 100 IU/l (reference range 10-50) and a γ glutamyl transferase concentration of 80 IU/l (range 10-50 ...
Nahum Méndez-Sánchez
doaj +5 more sources
Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome [PDF]
BMC MicrobiologyBackground Emerging evidence suggests that the gut microbiome plays a key role in metabolic diseases such as non-alcoholic fatty liver disease, yet the contribution of the gut mycobiome remains largely overlooked.
Ning Zheng +12 more
doaj +2 more sources
Non-Alcoholic Fatty Liver Disease [PDF]
Vnitřní lékařství, 2019 Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of a metabolic syndrome, is a leading cause of chronic liver disease worldwide with prevalence 17-46 % in adult population. NAFLD is associated with type 2 diabetes, obesity and genetic factors and includes a spectrum of potentially progressive liver disease that comprises of simple ...
Farrell, Geoffrey +3 more
+8 more sources
Non-alcoholic fatty liver disease [PDF]
The Lancet, 2021 Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of 25% and is a leading cause of cirrhosis and hepatocellular carcinoma. NAFLD encompasses a disease continuum from steatosis with or without mild inflammation (non-alcoholic fatty liver), to non-alcoholic steatohepatitis (NASH), which is characterised by necroinflammation and faster ...
Elizabeth E, Powell +2 more
openaire +3 more sources
Non-alcoholic fatty liver disease [PDF]
Clinical Medicine, 2018 Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of about 25%. Incidence is increasing with rising levels of obesity, type 2 diabetes and the metabolic syndrome, and NAFLD is predicted to become the leading cause of cirrhosis requiring liver transplantation in the next decade.
Maurice, J, Manousou, P
+8 more sources
Frontiers in Medicine, 2022 Background:Non-alcoholic fatty liver disease (NAFLD) is a global health problem affecting more than a quarter of the entire adult population. Both monocytes and high-density lipoprotein cholesterol (HDL-C) were found to participate in the progression of ...
Liping Wang +8 more
doaj +1 more source